|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
PHENOTHIAZINES, TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
PHENOTHIAZINES, TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
SIGNS OF HYPOGLYCEMIA MAY BE REDUCED OR ABSENT
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
THIAZIDES AND OTHER DIURETICS, TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
THIAZIDES AND OTHER DIURETICS, TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
PROGESTERONES TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|
INSULIN REQUIREMENT MAY BOTH INCREASE OR DECREASE BY THE DRUG
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
THIAZIDES AND OTHER DIURETICS, TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
PHENOTHIAZINES, TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
CYCLOPHOSPHAMIDE MAY BOTH INCREASE OR DECREASE THE BLOOD SUGAR LEVELS
|
HYPOGLYCEMIC EFFECT MAY INCREASE OR DECREASE
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
PROGESTERONES TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
INSULIN REQUIREMENT IS INCREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
PROGESTERONES TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
MAY EITHER POTENTIATE OR WEAKEN THE BLOOD GLUCOSE LOWERING EFFECT OF INSULIN
|
PROGESTERONES TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
PHENOTHIAZINES, TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
MAY EITHER POTENTIATE OR WEAKEN THE BLOOD GLUCOSE LOWERING EFFECT OF INSULIN
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
THIAZIDES AND OTHER DIURETICS, TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|
HYPOGLYCEMIC EFFECT IS REDUCED BY THE DRUG
|